Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generator
ABBOTT MEDICAL · Decision date Oct 27, 2026
What did the FDA decide?
The FDA recorded decision OK30 on 2026-10-27 for P140009/S143, a 30-Day Notice supplement to Abbott Medical's Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generator. The supplement reason is listed as a process change involving a manufacturer, sterilizer, packager or supplier. The recorded statement covers a change in manufacturing of the feedthrough component used in the Implantable Pulse Generators of the Spinal Cord Stimulator and Deep Brain Stimulator systems.
This action concerns a component-level manufacturing change rather than a new approval of the Liberta RC system or of any spinal cord or deep brain stimulation device. The device category is an implanted electrical stimulator for parkinsonian tremor, specialty Neurology, product code MHY. The source record includes no documents, so the feedthrough specification, change details and any conditions of approval are not available here and remain unknown.
FDA approval order statement
approval for a change in the manufacturing of the feedthrough component utilized in the Implantable Pulse Generators (IPGs) of the Spinal Cord Stimulator and Deep Brain Stimulator systems
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Neurology
- Decision date
- Oct 27, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P140009/S143
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- MHY
- Decision code
- OK30
- Decision date
- Oct 27, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.
- Applicant
- Abbott Medical
- Product code
- MHY
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P140009. Subsequent supplements may change the device or its indications.
FDA decision timeline
P140009 · Original PMA
BRIO NEUROSTIMULATION SYSTEM
P140009/S140 · Related supplement
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger
P140009/S139 · Related supplement
Infinity DBS IPG
P140009/S143 received
Application receipt date recorded by FDA.
P140009/S143 · FDA decision
30-Day Notice
P140009/S141 · Related supplement
Deep Brain Stimulation (DBS) EPG
P140009/S142 · Related supplement
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger
P140009/S144 · Related supplement
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)
Timeline entries are records held by MedtechLedger for P140009. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140009
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
BRIO NEUROSTIMULATION SYSTEMP140009 | ABBOTT MEDICAL | PMA approval | Jun 12, 2015 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 11, 2026 | FDA | |
Infinity DBS IPGP140009/S139 | ABBOTT MEDICAL | PMA supplement | Sep 23, 2026 | FDA |
Deep Brain Stimulation (DBS) EPGP140009/S141 | ABBOTT MEDICAL | PMA supplement | Oct 28, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code MHY
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA supplement | Nov 8, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 30, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 29, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 6, 2026 | FDA | |
MEDTRONIC ACTIVA TREMOR CONTROL SYSTEMP960009/S546 | Medtronic, Inc. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 6901 Prestion Rd., Plano, TX, 75024
Sources and methodology
- Original FDA record: P140009/S143
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
